文献速递湿疹皮炎与荨麻疹

儿童慢性荨麻疹:合并症、自然病史及早期缓解预测因素

Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria.
PubMed 文献 · JAMA Dermatol · 2017-01-01

该研究随访了139例儿童慢性荨麻疹患者,评估其合并症、自然病史及缓解预测因素。结果显示年缓解率为10.3%,BAT阳性(CD63>1.8%)与缓解可能性增加相关(HR 2.33),而嗜碱性粒细胞存在则降低缓解可能性(HR 0.40)。

要点

  • 儿童慢性荨麻疹年缓解率仅10.3%,总体缓解率低
  • BAT阳性(CD63>1.8%)者1年缓解可能性是阴性者的2.33倍
  • 外周血嗜碱性粒细胞存在与缓解可能性降低相关(HR 0.40)

核心结论

  • 儿童慢性荨麻疹缓解率低,年缓解率为10.3%。
  • BAT阳性(CD63>1.8%)和嗜碱性粒细胞计数有助于预测缓解可能性。

研究设计与样本

  • 研究为单中心三级转诊中心随访的儿童慢性荨麻疹队列,纳入2013至2015年间就诊、风团持续至少6周的139例18岁以下儿童。

主要发现

  • 6例儿童有自身免疫合并症,如甲状腺炎和1型糖尿病。
  • 家族成员中自身免疫性疾病占24例(17%),慢性荨麻疹占17例(12%)。
  • 58%的患者BAT结果阳性(CD63水平>1.8%)。
  • BAT阳性(CD63>1.8%)者1年缓解可能性是阴性者的2.33倍(HR 2.33;95%CI 1.08-5.05)。

关键数值与推荐

  • 缓解定义为至少1年无风团且未治疗。
  • BAT阳性定义为CD63水平>1.8%。

临床怎么用

  • 对于儿童慢性荨麻疹,可检测BAT和嗜碱性粒细胞计数以辅助预测缓解可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Chronic urticaria (CU) affects 0.1% to 0.3% of children. Most cases have no identifiable trigger and are classified as chronic spontaneous urticaria (CSU). At least half of patients with CSU may have an autoimmune etiology that can be determined in vitro using the basophil activation test (BAT). While 30% to 55% of CU cases resolve spontaneously within 5 years in adults, the natural history and predictors of resolution in children are not known. OBJECTIVE: To assess the comorbidities, natural history of CU, and its subtypes in children and identify predictors of resolution. DESIGN, SETTING, AND PARTICIPANTS: We followed a pediatric cohort with chronic urticaria that presented with hives lasting at least 6 weeks between 2013 and 2015 at a single tertiary care referral center. EXPOSURES: Data were collected on disease activity, comorbidities, physical triggers, BAT results, complete blood cell count, C-reactive protein levels, thyroid-stimulating hormone levels, and thyroid peroxidase antibodies. MAIN OUTCOMES AND MEASURES: We assessed the rate of resolution (defined as absence of hives for at least 1 year with no treatment) and the association with clinical and laboratory markers. RESULTS: The cohort comprised 139 children younger than 18 years old. Thirty-one patients (20%) had inducible urticaria, most commonly cold induced. Six children had autoimmune comorbidity, such as thyroiditis and type 1 diabetes. Autoimmune disorders (24 patients [17%]) and CU (17 patients [12%]) were common in family members. Positive BAT results (CD63 levels > 1.8%) were found in 58% of patients. Patients with positive BAT results (CD63 level >1.8%) were twice as likely to resolve after 1 year compared with negative BAT results (hazard ratio [HR], 2.33; 95% CI, 1.08-5.05). In contrast, presence of basophils decreased the likelihood of resolution (HR, 0.40; 95% CI, 0.20-0.99). No correlation with age was found. Chronic urticaria resolved in 43 patients, with a rate of resolution of 10.3% per year. Levels of CD63 higher than 1.8% and absence of basophils were associated with earlier disease resolution. CONCLUSIONS AND RELEVANCE: Resolution rate in children with CU is low. The presence of certain biomarkers (positive BAT result and basophil count) may help to predict the likelihood of resolution.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Netchiporouk E, Sasseville D, Moreau L, et al. Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria. JAMA Dermatol. 2017. PMID: 28973060. doi:10.1001/jamadermatol.2017.3182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。